Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease

Zhewen Ren; Anke Wesselius; Coen D.A. Stehouwer; Martijn C.G.J. Brouwers

doi:10.1016/j.ecl.2023.01.002

Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease

Zhewen Ren
, Anke Wesselius
, Coen D.A. Stehouwer
, Martijn C.G.J. Brouwers^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

255 Downloads (Pure)

Original language	English
Pages (from-to)	459-468
Number of pages	10
Journal	Endocrinology and Metabolism Clinics of North America
Volume	52
Issue number	3
Early online date	Jul 2023
DOIs	https://doi.org/10.1016/j.ecl.2023.01.002
Publication status	Published - 1 Sept 2023

Keywords

Cardiovascular disease
Metabolic dysfunction-associated fatty liver disease
Nonalcoholic fatty liver disease
Preventive measures
Treatment

Access to Document

10.1016/j.ecl.2023.01.002

Full TextFinal published version, 524 KBLicence: Taverne

Cite this

@article{d1d3b9aa68c8447b85816c20cd3712f5,

title = "Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease",

keywords = "Cardiovascular disease, Metabolic dysfunction-associated fatty liver disease, Nonalcoholic fatty liver disease, Preventive measures, Treatment",

author = "Zhewen Ren and Anke Wesselius and Stehouwer, \{Coen D.A.\} and Brouwers, \{Martijn C.G.J.\}",

year = "2023",

month = sep,

day = "1",

doi = "10.1016/j.ecl.2023.01.002",

language = "English",

volume = "52",

pages = "459--468",

journal = "Endocrinology and Metabolism Clinics of North America",

issn = "0889-8529",

publisher = "W.B. Saunders",

number = "3",

}

TY - JOUR

T1 - Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease

AU - Ren, Zhewen

AU - Wesselius, Anke

AU - Stehouwer, Coen D.A.

AU - Brouwers, Martijn C.G.J.

PY - 2023/9/1

Y1 - 2023/9/1

KW - Cardiovascular disease

KW - Metabolic dysfunction-associated fatty liver disease

KW - Nonalcoholic fatty liver disease

KW - Preventive measures

KW - Treatment

U2 - 10.1016/j.ecl.2023.01.002

DO - 10.1016/j.ecl.2023.01.002

M3 - Article

C2 - 37495337

SN - 0889-8529

VL - 52

SP - 459

EP - 468

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

IS - 3

ER -